Bulk Manufacturer of Controlled Substances Application: SPECGX LLC, 26943 [2021-10412]
Download as PDF
<![CDATA[
26943
Federal Register / Vol. 86, No. 94 / Tuesday, May 18, 2021 / Notices
DEPARTMENT OF JUSTICE
substance(s). Refer to SUPPLEMENTARY
listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 19, 2021. Such persons
may also file a written request for a
hearing on the application on or before
July 19, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
INFORMATION
Drug Enforcement Administration
[Docket No. DEA–835]
Bulk Manufacturer of Controlled
Substances Application: SPECGX LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
SPECGX LLC, has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
SUMMARY:
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
In
accordance with 21 CFR 1301.33(a), this
is notice that on February 5, 2021,
SPECGX LLC, 3600 N 2nd Street, Saint
Louis, Missouri 63147, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
jbell on DSKJLSW7X2PROD with NOTICES
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
Dihydromorphine .............................................................................................................................................................
Difenoxin ..........................................................................................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Normorphine ....................................................................................................................................................................
Alphamethadol .................................................................................................................................................................
Betamethadol ...................................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...............................................................................
Butyryl Fentanyl ...............................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .....................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Lisdexamfetamine ............................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Nabilone ...........................................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) .....................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate-A ..............................................................................................................................................
Meperidine intermediate-B ..............................................................................................................................................
Meperidine intermediate-C ..............................................................................................................................................
Methadone .......................................................................................................................................................................
Methadone intermediate ..................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Oripavine .........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Opium tincture .................................................................................................................................................................
Opium, powdered ............................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. In reference to dug code
7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture this
VerDate Sep<11>2014
16:40 May 17, 2021
Jkt 253001
drug as synthetic. No other activities for
PO 00000
2010
7370
9053
9145
9168
9307
9313
9605
9609
9634
9821
9822
9850
1100
1105
1205
1724
7379
8333
9050
9120
9143
9150
9170
9180
9193
9220
9230
9232
9233
9234
9250
9254
9273
9300
9330
9333
9630
9639
9652
9668
9737
9739
9740
9780
9801
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
these drug codes are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–10412 Filed 5–17–21; 8:45 am]
BILLING CODE P
Frm 00052
Fmt 4703
Sfmt 9990
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 86, Number 94 (Tuesday, May 18, 2021)]
[Notices]
[Page 26943]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10412]
[[Page 26943]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-835]
Bulk Manufacturer of Controlled Substances Application: SPECGX
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: SPECGX LLC, has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before July 19, 2021.
Such persons may also file a written request for a hearing on the
application on or before July 19, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on February 5, 2021, SPECGX LLC, 3600 N 2nd Street,
Saint Louis, Missouri 63147, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid................ 2010 I
Tetrahydrocannabinols.................... 7370 I
Codeine-N-oxide.......................... 9053 I
Dihydromorphine.......................... 9145 I
Difenoxin................................ 9168 I
Morphine-N-oxide......................... 9307 I
Normorphine.............................. 9313 I
Alphamethadol............................ 9605 I
Betamethadol............................. 9609 I
Norlevorphanol........................... 9634 I
Acetyl Fentanyl (N-(1-phenethylpiperidin- 9821 I
4-yl)-N-phenylacetamide).
Butyryl Fentanyl......................... 9822 I
Fentanyl related-compounds as defined in 9850 I
21 CFR 1308.11(h).
Amphetamine.............................. 1100 II
Methamphetamine.......................... 1105 II
Lisdexamfetamine......................... 1205 II
Methylphenidate.......................... 1724 II
Nabilone................................. 7379 II
ANPP (4-Anilino-N-phenethyl-4-piperidine) 8333 II
Codeine.................................. 9050 II
Dihydrocodeine........................... 9120 II
Oxycodone................................ 9143 II
Hydromorphone............................ 9150 II
Diphenoxylate............................ 9170 II
Ecgonine................................. 9180 II
Hydrocodone.............................. 9193 II
Levorphanol.............................. 9220 II
Meperidine............................... 9230 II
Meperidine intermediate-A................ 9232 II
Meperidine intermediate-B................ 9233 II
Meperidine intermediate-C................ 9234 II
Methadone................................ 9250 II
Methadone intermediate................... 9254 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine................................. 9300 II
Oripavine................................ 9330 II
Thebaine................................. 9333 II
Opium tincture........................... 9630 II
Opium, powdered.......................... 9639 II
Oxymorphone.............................. 9652 II
Noroxymorphone........................... 9668 II
Alfentanil............................... 9737 II
Remifentanil............................. 9739 II
Sufentanil............................... 9740 II
Tapentadol............................... 9780 II
Fentanyl................................. 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for the internal use intermediates or for sale to its
customers. In reference to dug code 7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture this drug as synthetic. No other
activities for these drug codes are authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-10412 Filed 5-17-21; 8:45 am]
BILLING CODE P
